Enzyme, powered by the MLN token, is a digital asset management platform that strives to streamline the management of digital assets. It provides a unified, user-friendly on-chain system that allows access to digital assets and DeFi from a single application. Enzyme aims to eliminate operational risks associated with managing crypto and DeFi assets without purpose-built smart-contract permissions and controls. It provides a robust suite of programmable risk management and governance tools to protect assets. Enzyme also maintains sophisticated on-chain data pipelines, ensuring data is auditable and trustworthy, promoting a future based on transparency and auditability.

Enzyme operates through a system of vaults, each representing a unique portfolio with its own strategy, asset allocation, and investment goals. Users can create multiple vaults and customize each one according to their preferences. Enzyme provides tools for managing and monitoring these portfolios, including performance metrics and detailed reporting. This makes it easy for users to track the performance of their assets and make informed decisions about how to manage their portfolios over time. Enzyme also provides real-time reporting and performance dashboards with key performance and risk metrics, and reports that provide easily readable and provable data on all transactions at any point in history.

Enzyme has a wide range of potential use cases. For instance, it can be used for treasury management, allowing organizations to manage their treasury simply, securely, and transparently. It can also be used to set up an on-chain DeFi fund, with Enzyme taking care of all fund operations and administration using smart-contract automation. Additionally, users can build their own indexes in minutes and have them rebalance automatically on-chain or off-chain. Enzyme also allows anyone to build, scale, and monetize investment strategies using the protocol's non-custodial Vaults. These strategies can span the spectrum from traditional discretionary allocators to DeFi-native combinations of any of the primitives with which Enzyme integrates.

Enzyme, formerly known as the Melon Protocol, was initially developed by the private company Melonport. After the dissolution of Melonport, the protocol was transferred to the Enzyme Council. The protocol has been on the mainnet since February 2019 and was the first DeFi protocol to decentralize its governance. Enzyme v2, a completely re-architected protocol with modularity and extensibility at the core of its design, was launched to the mainnet in January 2021. The Enzyme token, MLN, is used to access the MLN network and incentivize developers to build on Enzyme.

Actualizamos nuestro Enzyme a la moneda ARS en tiempo real. Consulta el precio de Enzyme en tiempo real en Coinbase.

La capitalización de mercado actual de Enzyme es 17,052 mil M ARS. Una capitalización de mercado alta implica que el activo es muy valorado por el mercado.

El máximo histórico de Enzyme es 379.413,22 ARS. Este máximo histórico es el precio más alto pagado por Enzyme desde su lanzamiento.

Durante las últimas 24 horas, el volumen de operaciones de Enzyme es de 30,469 mil M ARS.

Los activos que tienen una capitalización de mercado similar a Enzyme incluyen Inverse Finance, Bitcoin Gold, Collector Crypt y muchos otros. Para ver una lista completa, consulte nuestros activos de capitalización de mercado comparables.

La oferta circulante actual de Enzyme es de 3,3 millones.

Enzyme se clasifica 212 entre los activos negociables en Coinbase. La popularidad se basa actualmente en la capitalización de mercado relativa.

Actualmente, el 63 % de los usuarios de Coinbase están comprando Enzyme. En otras palabras, el 63 % de los clientes de Coinbase han aumentado su posición neta en Enzyme durante las últimas 24 horas a través de operaciones.